Early treatment of Kallmann syndrome may prevent eunuchoid appearance and behavior

Abstract Kallmann syndrome (KS) is a genetic disorder which combines hypogonadotropic hypogonadism and anosmia. Hypogonadism is characterized by the absence or reduced levels of gonadotropin-releasing hormone and anosmia due to olfactory bulb aplasia. KS treatment usually begins just before puberty,...

Full description

Saved in:
Bibliographic Details
Published in:Medical hypotheses 2014-01, Vol.82 (1), p.74-76
Main Authors: Castañeyra-Perdomo, Agustín, Castañeyra-Ruiz, Leandro, González-Marrero, Ibrahim, Castañeyra-Ruiz, Agustin, Gonzalez-Toledo, Juan M, Castañeyra-Ruiz, Maria, Carmona-Calero, Emilia M
Format: Article
Language:English
Subjects:
Age Factors
Behavioral Symptoms - prevention & control
Brain - growth & development
Brain - physiopathology
Humans
Internal Medicine
Kallmann Syndrome - drug therapy
Kallmann Syndrome - pathology
Models, Biological
Sexual Maturation - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Kallmann syndrome (KS) is a genetic disorder which combines hypogonadotropic hypogonadism and anosmia. Hypogonadism is characterized by the absence or reduced levels of gonadotropin-releasing hormone and anosmia due to olfactory bulb aplasia. KS treatment usually begins just before puberty, but brain sexual maturation occurs long before puberty normally at perinatal age. As brain cells implicated in the development of the olfactory and reproductive system have a rostral and a caudal origin, and the rostral origin is affected by aplasia in KS and the caudal origin does not seem to be affected, the early treatment of KS, as proposed in this paper, is to attain brain sexual maturation at the most appropriate age possible to prevent the eunuchoid behavior and appearance observed in KS.
ISSN:0306-9877
1532-2777
DOI:10.1016/j.mehy.2013.11.011